<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND AIM: The association of <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> in <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> (GS) with a decrease in prevalence of <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> is a well-known phenomenon </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, the state of <z:chebi fb="2" ids="39026">low-density lipoprotein</z:chebi> (<z:chebi fb="15" ids="39026">LDL</z:chebi>) oxidation which has been postulated to be a significant determinant at the etiopathogenesis of atherosclerotic disorders was investigated among individuals with GS </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: For this purpose, serum cholesterol, <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi>, <z:chebi fb="1" ids="47775">high-density lipoprotein cholesterol</z:chebi>, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, <z:chebi fb="3" ids="27226">uric acid</z:chebi>, <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A and B, <z:chebi fb="0" ids="16990">bilirubins</z:chebi>, <z:chebi fb="0" ids="33202">thiobarbituric acid</z:chebi>-reactive substances, and the sensitivity of <z:chebi fb="15" ids="39026">LDL</z:chebi> oxidation levels, as well as serum alanine aminotransferase, <z:chebi fb="0" ids="29995">aspartate</z:chebi> aminotranserfase, <z:chebi fb="0" ids="24190">gamma glutamyl</z:chebi> transferase, and alkaline phosphatase activities, were determined in 17 patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> and 15 healthy adults </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: There was no significant difference between the groups except the indirect <z:chebi fb="0" ids="16990">bilirubin</z:chebi> parameter (P &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>In comparison with the healthy individuals, <z:chebi fb="15" ids="39026">LDL</z:chebi> oxidation levels between 75 and 120 min were significantly lower (P &lt; 0.005) along with prolonged lag-phase in GS patients, indicating a delay in oxidation susceptibility </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: It is suggested that the <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> leading to a lag-phase prolongation in <z:chebi fb="15" ids="39026">LDL</z:chebi> oxidation and a decrease in <z:chebi fb="15" ids="39026">LDL</z:chebi> oxidation may be reason for the low percentage of <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> </plain></SENT>
</text></document>